Nanoform has filed for a dual listing in Sweden and Finland, marking the first time that a University of Helsinki spinout is seeking an initial public offering.
Nanoform, a Finland-based drug particle engineering spinout of University of Helsinki, yesterday priced its shares at €3.45 ($3.78) and will raise $76.7m when it goes public on June 4.
The spinout will issue approximately 20.3 million shares and will undertake a dual listing on the Nasdaq First North Premier Growth Markets in Sweden and Finland.
Additionally, the co-founders and certain shareholders, including the institution’s endowment Helsinki University Funds, will put up more than 2.3 million shares for sale.
